A438079 [Ligand Id: 4118] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL377219 (A-438079) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| P2X7/P2X purinoceptor 7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4805] [GtoPdb: 484] [UniProtKB: Q99572] | ||||||||
| ChEMBL | Displacement of [3H]-A-804598 from human P2X7 receptor expressed in HEK293 cell membrane by in vitro binding assay | B | 7.17 | pKi | 68 | nM | Ki | J Med Chem (2021) 64: 4891-4902 [PMID:33822617] |
| ChEMBL | Antagonist activity at human P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium-flux measured after 60 mins by FLIPR analysis | B | 5.68 | pIC50 | 2100 | nM | IC50 | J Med Chem (2021) 64: 4891-4902 [PMID:33822617] |
| ChEMBL | Antagonist activity at human P2X7 receptor in expressed in HEK293 cells assessed as inhibition of BzATP-induced EtBr uptake | B | 6.52 | pIC50 | 300 | nM | IC50 | Eur J Med Chem (2018) 151: 462-481 [PMID:29649742] |
| GtoPdb | - | - | 6.9 | pIC50 | ~125 | nM | IC50 | Br J Pharmacol (2007) 151: 571-9 [PMID:17471177] |
| ChEMBL | Antagonist activity at human P2X7 receptor expressed in human 1321N1 cells assessed as inhibition of calcium flux by FLIPR | F | 6.9 | pIC50 | 125.89 | nM | IC50 | J Med Chem (2006) 49: 3659-3666 [PMID:16759108] |
| ChEMBL | Antagonist activity at P2X7 receptor in human THP1 cells assessed as inhibition of BzATP-induced ethidium uptake | F | 6.9 | pIC50 | 125.89 | nM | IC50 | J Med Chem (2009) 52: 3123-3141 [PMID:19191585] |
| ChEMBL | Antagonist activity at human recombinant P2X7 receptor assessed as inhibition of BzATP-induced calcium flux by FLIPR assay | F | 6.91 | pIC50 | 123.03 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 2089-2092 [PMID:18272366] |
| ChEMBL | Antagonist activity at human recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of benzoylbenzoic ATP-induced calcium production by FLIPR assay | F | 6.91 | pIC50 | 123.03 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 3297-3300 [PMID:21536435] |
| P2X7/P2X purinoceptor 7 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5183] [GtoPdb: 484] [UniProtKB: Q9Z1M0] | ||||||||
| ChEMBL | Antagonist activity at mouse P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium-flux measured after 60 mins by FLIPR analysis | B | 5.54 | pIC50 | 2900 | nM | IC50 | J Med Chem (2021) 64: 4891-4902 [PMID:33822617] |
| P2X7/P2X purinoceptor 7 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2496] [GtoPdb: 484] [UniProtKB: Q64663] | ||||||||
| ChEMBL | Displacement of [3H]-A-804598 from rat P2X7 receptor expressed in HEK293 cell membrane by in vitro binding assay | B | 6.7 | pKi | 200 | nM | Ki | J Med Chem (2021) 64: 4891-4902 [PMID:33822617] |
| ChEMBL | Antagonist activity at rat P2X7 receptor expressed in HEK293 cells assessed as inhibition of BzATP-induced calcium-flux measured after 60 mins by FLIPR analysis | B | 6.04 | pIC50 | 910 | nM | IC50 | J Med Chem (2021) 64: 4891-4902 [PMID:33822617] |
| ChEMBL | Antagonist activity at rat P2X7 receptor expressed in human 1321N1 cells assessed as inhibition of calcium flux by FLIPR | F | 6.5 | pIC50 | 316.23 | nM | IC50 | J Med Chem (2006) 49: 3659-3666 [PMID:16759108] |
| ChEMBL | Activity at rat P2X7 receptor expressed in HEK cells assessed as effect on BzATP-induced ethidium uptake | B | 6.5 | pIC50 | 316.23 | nM | IC50 | J Med Chem (2009) 52: 3123-3141 [PMID:19191585] |
| ChEMBL | Antagonist activity at rat recombinant P2X7 receptor assessed as inhibition of BzATP-induced calcium flux by FLIPR assay | F | 6.51 | pIC50 | 309.03 | nM | IC50 | Bioorg Med Chem Lett (2008) 18: 2089-2092 [PMID:18272366] |
| ChEMBL | Antagonist activity at rat recombinant P2X7 receptor expressed in HEK293 cells assessed as inhibition of benzoylbenzoic ATP-induced calcium production by FLIPR assay | F | 6.51 | pIC50 | 309.03 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 3297-3300 [PMID:21536435] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
